Form 6-K Telix Pharmaceuticals For: Jun 30

August 20, 2026 6:05 AM EDT
FALSEJun. 30, 20260002007191--12-31iso4217:USDiso4217:USDxbrli:sharestlx:Productxbrli:pureiso4217:AUDxbrli:sharesiso4217:AUDxbrli:shares00020071912026-01-012026-06-3000020071912025-01-012025-06-3000020071912026-06-3000020071912025-12-310002007191ifrs-full:IssuedCapitalMember2025-12-310002007191ifrs-full:CapitalReserveMember2025-12-310002007191ifrs-full:OtherReservesMember2025-12-310002007191ifrs-full:RetainedEarningsMember2025-12-310002007191ifrs-full:RetainedEarningsMember2026-01-012026-06-300002007191ifrs-full:OtherReservesMember2026-01-012026-06-300002007191ifrs-full:IssuedCapitalMember2026-01-012026-06-300002007191ifrs-full:CapitalReserveMember2026-01-012026-06-300002007191ifrs-full:IssuedCapitalMember2026-06-300002007191ifrs-full:CapitalReserveMember2026-06-300002007191ifrs-full:OtherReservesMember2026-06-300002007191ifrs-full:RetainedEarningsMember2026-06-300002007191ifrs-full:IssuedCapitalMember2024-12-310002007191ifrs-full:CapitalReserveMember2024-12-310002007191ifrs-full:OtherReservesMember2024-12-310002007191ifrs-full:RetainedEarningsMember2024-12-3100020071912024-12-310002007191ifrs-full:RetainedEarningsMember2025-01-012025-06-300002007191ifrs-full:OtherReservesMember2025-01-012025-06-300002007191ifrs-full:IssuedCapitalMember2025-01-012025-06-300002007191ifrs-full:CapitalReserveMember2025-01-012025-06-300002007191ifrs-full:IssuedCapitalMember2025-06-300002007191ifrs-full:CapitalReserveMember2025-06-300002007191ifrs-full:OtherReservesMember2025-06-300002007191ifrs-full:RetainedEarningsMember2025-06-3000020071912025-06-300002007191tlx:PrecisionMedicineMemberifrs-full:OperatingSegmentsMember2026-01-012026-06-300002007191tlx:TherapeuticsMemberifrs-full:OperatingSegmentsMember2026-01-012026-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:OperatingSegmentsMember2026-01-012026-06-300002007191ifrs-full:EliminationOfIntersegmentAmountsMember2026-01-012026-06-300002007191ifrs-full:OperatingSegmentsMember2026-01-012026-06-300002007191tlx:PrecisionMedicineMemberifrs-full:OperatingSegmentsMember2025-01-012025-06-300002007191tlx:TherapeuticsMemberifrs-full:OperatingSegmentsMember2025-01-012025-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:OperatingSegmentsMember2025-01-012025-06-300002007191ifrs-full:EliminationOfIntersegmentAmountsMember2025-01-012025-06-300002007191ifrs-full:OperatingSegmentsMember2025-01-012025-06-300002007191ifrs-full:UnallocatedAmountsMember2026-01-012026-06-300002007191ifrs-full:UnallocatedAmountsMember2025-01-012025-06-300002007191tlx:PrecisionMedicineMemberifrs-full:OperatingSegmentsMember2026-06-300002007191tlx:TherapeuticsMemberifrs-full:OperatingSegmentsMember2026-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:OperatingSegmentsMember2026-06-300002007191ifrs-full:OperatingSegmentsMember2026-06-300002007191ifrs-full:MaterialReconcilingItemsMember2026-06-300002007191ifrs-full:MaterialReconcilingItemsMember2026-01-012026-06-300002007191tlx:PrecisionMedicineMemberifrs-full:OperatingSegmentsMember2025-12-310002007191tlx:TherapeuticsMemberifrs-full:OperatingSegmentsMember2025-12-310002007191tlx:ManufacturingSolutionsMemberifrs-full:OperatingSegmentsMember2025-12-310002007191ifrs-full:OperatingSegmentsMember2025-12-310002007191ifrs-full:MaterialReconcilingItemsMember2025-12-310002007191tlx:PrecisionMedicineMemberifrs-full:OperatingSegmentsMember2025-01-012025-12-310002007191tlx:TherapeuticsMemberifrs-full:OperatingSegmentsMember2025-01-012025-12-310002007191tlx:ManufacturingSolutionsMemberifrs-full:OperatingSegmentsMember2025-01-012025-12-310002007191ifrs-full:OperatingSegmentsMember2025-01-012025-12-310002007191ifrs-full:MaterialReconcilingItemsMember2025-01-012025-12-3100020071912025-01-012025-12-310002007191country:US2026-01-012026-06-300002007191country:US2025-01-012025-06-300002007191ifrs-full:ForeignCountriesMember2026-01-012026-06-300002007191ifrs-full:ForeignCountriesMember2025-01-012025-06-300002007191country:AU2026-06-300002007191country:AU2025-12-310002007191country:BE2026-06-300002007191country:BE2025-12-310002007191country:CA2026-06-300002007191country:CA2025-12-310002007191country:GB2026-06-300002007191country:GB2025-12-310002007191country:US2026-06-300002007191country:US2025-12-310002007191ifrs-full:ForeignCountriesMember2026-06-300002007191ifrs-full:ForeignCountriesMember2025-12-310002007191tlx:PrecisionMedicineMemberifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2026-01-012026-06-300002007191tlx:PrecisionMedicineMemberifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2025-01-012025-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2026-01-012026-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:GoodsOrServicesTransferredAtPointInTimeMember2025-01-012025-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2026-01-012026-06-300002007191tlx:ManufacturingSolutionsMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2025-01-012025-06-300002007191tlx:PrecisionMedicineMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2026-01-012026-06-300002007191tlx:PrecisionMedicineMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2025-01-012025-06-300002007191tlx:TherapeuticsMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2026-01-012026-06-300002007191tlx:TherapeuticsMemberifrs-full:GoodsOrServicesTransferredOverTimeMember2025-01-012025-06-300002007191ifrs-full:CostOfSalesMember2026-01-012026-06-300002007191ifrs-full:CostOfSalesMember2025-01-012025-06-3000020071912026-04-300002007191ifrs-full:GoodwillMember2025-12-310002007191ifrs-full:BrandNamesMember2025-12-310002007191tlx:CustomerRelationshipsAndBrandsMember2025-12-310002007191ifrs-full:ComputerSoftwareMember2025-12-310002007191ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2025-12-310002007191ifrs-full:LicencesMember2025-12-310002007191ifrs-full:GoodwillMember2026-01-012026-06-300002007191ifrs-full:BrandNamesMember2026-01-012026-06-300002007191tlx:CustomerRelationshipsAndBrandsMember2026-01-012026-06-300002007191ifrs-full:ComputerSoftwareMember2026-01-012026-06-300002007191ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2026-01-012026-06-300002007191ifrs-full:LicencesMember2026-01-012026-06-300002007191ifrs-full:GoodwillMember2026-06-300002007191ifrs-full:BrandNamesMember2026-06-300002007191tlx:CustomerRelationshipsAndBrandsMember2026-06-300002007191ifrs-full:ComputerSoftwareMember2026-06-300002007191ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2026-06-300002007191ifrs-full:LicencesMember2026-06-300002007191ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2026-06-300002007191ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2026-06-300002007191ifrs-full:GrossCarryingAmountMembertlx:CustomerRelationshipsAndBrandsMember2026-06-300002007191ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2026-06-300002007191ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2026-06-300002007191ifrs-full:GrossCarryingAmountMemberifrs-full:LicencesMember2026-06-300002007191ifrs-full:GrossCarryingAmountMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:GoodwillMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMembertlx:CustomerRelationshipsAndBrandsMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LicencesMember2026-06-300002007191ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-06-300002007191ifrs-full:GoodwillMember2024-12-310002007191ifrs-full:BrandNamesMember2024-12-310002007191tlx:CustomerRelationshipsAndBrandsMember2024-12-310002007191ifrs-full:ComputerSoftwareMember2024-12-310002007191ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2024-12-310002007191ifrs-full:LicencesMember2024-12-310002007191ifrs-full:GoodwillMember2025-01-012025-12-310002007191ifrs-full:BrandNamesMember2025-01-012025-12-310002007191tlx:CustomerRelationshipsAndBrandsMember2025-01-012025-12-310002007191ifrs-full:ComputerSoftwareMember2025-01-012025-12-310002007191ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2025-01-012025-12-310002007191ifrs-full:LicencesMember2025-01-012025-12-310002007191ifrs-full:GrossCarryingAmountMemberifrs-full:GoodwillMember2025-12-310002007191ifrs-full:GrossCarryingAmountMemberifrs-full:BrandNamesMember2025-12-310002007191ifrs-full:GrossCarryingAmountMembertlx:CustomerRelationshipsAndBrandsMember2025-12-310002007191ifrs-full:GrossCarryingAmountMemberifrs-full:ComputerSoftwareMember2025-12-310002007191ifrs-full:GrossCarryingAmountMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2025-12-310002007191ifrs-full:GrossCarryingAmountMemberifrs-full:LicencesMember2025-12-310002007191ifrs-full:GrossCarryingAmountMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:GoodwillMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BrandNamesMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMembertlx:CustomerRelationshipsAndBrandsMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:ComputerSoftwareMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LicencesMember2025-12-310002007191ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-12-310002007191tlx:ConvertibleNoteDue2031NewBondsMember2026-04-150002007191tlx:ConvertibleNoteDue2029ExistingBondsMember2026-04-152026-04-150002007191tlx:ConvertibleNoteDue2029ExistingBondsMember2026-04-150002007191tlx:ConvertibleNoteDue2029ExistingBondsMember2026-05-012026-05-310002007191tlx:ConvertibleBondsMember2025-12-310002007191tlx:ConvertibleBondsMember2024-12-310002007191tlx:ConvertibleBondsMember2026-01-012026-06-300002007191tlx:ConvertibleBondsMember2025-01-012025-12-310002007191tlx:ConvertibleNoteDue2029ExistingBondsMember2026-01-012026-06-300002007191tlx:ConvertibleNoteDue2029ExistingBondsMember2025-01-012025-12-310002007191tlx:ConvertibleNoteDue2031NewBondsMember2026-06-300002007191tlx:ConvertibleNoteDue2031NewBondsMember2025-12-310002007191tlx:ConvertibleBondsMember2026-06-300002007191tlx:BankLoansMember2026-06-300002007191tlx:BankLoansMember2025-12-310002007191tlx:ConvertibleBondsMember2026-06-300002007191tlx:ConvertibleBondsMember2025-12-310002007191ifrs-full:LaterThanOneMonthAndNotLaterThanSixMonthsMember2026-06-300002007191ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2026-06-300002007191ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2026-06-300002007191ifrs-full:LaterThanFiveYearsMember2026-06-300002007191ifrs-full:LaterThanOneMonthAndNotLaterThanSixMonthsMember2025-12-310002007191ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember2025-12-310002007191ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember2025-12-310002007191ifrs-full:LaterThanFiveYearsMember2025-12-310002007191ifrs-full:IssuedCapitalMember2025-01-012025-12-310002007191tlx:DedicaidGmbHMemberifrs-full:IssuedCapitalMember2026-01-012026-06-300002007191tlx:DedicaidGmbHMemberifrs-full:IssuedCapitalMember2025-01-012025-12-310002007191tlx:LightpointMedicalMemberifrs-full:IssuedCapitalMember2026-01-012026-06-300002007191tlx:LightpointMedicalMemberifrs-full:IssuedCapitalMember2025-01-012025-12-310002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2026-01-012026-06-300002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2025-01-012025-12-310002007191tlx:DedicaidGmbHMemberifrs-full:IssuedCapitalMember2023-04-272023-04-270002007191ifrs-full:IssuedCapitalMember2023-04-272023-04-270002007191tlx:LightpointMedicalMemberifrs-full:IssuedCapitalMember2023-11-012023-11-010002007191tlx:LightpointMedicalMemberifrs-full:IssuedCapitalMember2023-11-010002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2025-01-302025-01-300002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2025-01-300002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2026-05-082026-05-080002007191tlx:ImaginAbIncMemberifrs-full:IssuedCapitalMember2026-05-080002007191tlx:ImaginAbIncMember2026-05-082026-05-080002007191ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2026-01-012026-06-300002007191ifrs-full:OrdinarySharesMemberifrs-full:IssuedCapitalMember2025-01-012025-06-300002007191ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2025-12-310002007191ifrs-full:ReserveOfSharebasedPaymentsMember2025-12-310002007191ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2025-12-310002007191ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2026-01-012026-06-300002007191ifrs-full:ReserveOfSharebasedPaymentsMember2026-01-012026-06-300002007191ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2026-01-012026-06-300002007191ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2026-06-300002007191ifrs-full:ReserveOfSharebasedPaymentsMember2026-06-300002007191ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2026-06-300002007191ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2024-12-310002007191ifrs-full:ReserveOfSharebasedPaymentsMember2024-12-310002007191ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2024-12-310002007191ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2025-01-012025-12-310002007191ifrs-full:ReserveOfSharebasedPaymentsMember2025-01-012025-12-310002007191ifrs-full:ReserveOfGainsAndLossesOnFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeMember2025-01-012025-12-310002007191ifrs-full:OtherReservesMember2025-01-012025-12-310002007191ifrs-full:Level1OfFairValueHierarchyMemberifrs-full:EquityPriceRiskMember2026-01-012026-06-300002007191ifrs-full:Level1OfFairValueHierarchyMemberifrs-full:EquityPriceRiskMember2025-01-012025-12-310002007191ifrs-full:Level3OfFairValueHierarchyMembertlx:DiscountRateRiskMember2026-01-012026-06-300002007191ifrs-full:Level3OfFairValueHierarchyMembertlx:DiscountRateRiskMember2025-01-012025-12-310002007191ifrs-full:Level3OfFairValueHierarchyMembertlx:SalesVolumeRiskMember2026-01-012026-06-300002007191ifrs-full:Level3OfFairValueHierarchyMembertlx:SalesVolumeRiskMember2025-01-012025-12-310002007191ifrs-full:NotLaterThanOneYearMember2026-06-300002007191ifrs-full:LaterThanOneYearMember2026-06-300002007191ifrs-full:NotLaterThanOneYearMember2025-12-310002007191ifrs-full:LaterThanOneYearMember2025-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August, 2026
 
Commission File Number: 001-42128
 
Telix Pharmaceuticals Limited
(Translation of registrant’s name into English)
 
55 Flemington Road
North Melbourne, Victoria 3051, Australia
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-
F.
 
Form 20-F Form 40-F
 
 
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
 
On August 20, 2026  (Melbourne, Australia), Telix Pharmaceuticals Limited ( “Telix”) filed the following
announcements with the Australian Securities Exchange titled: (i) “Telix H1 2026 Results Presentation,” (ii) “Telix
H1 2026 Appendix 4D and Interim Report,” and (iii) “Telix H1 2026 Results Announcement,” copies of which are
attached to this Form 6-K as Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3, respectively.
Also attached as Exhibit 99.4 to this Form 6-K, are copies of Telix’s unaudited interim consolidated financial
statements for the half-year ended June 30, 2026, and the related Operating and Financial Review discussion for the
half-year ended June 30, 2026, formatted in Extensible Business Reporting Language (“XBRL”).
Exhibits 99.2 and 99.4 are incorporated by reference into Telix’s Registration Statement on Form F-3ASR (File No.
333-293611) and Registration Statement on Form S-8 (File No. 333-283917).
Telix H1 2026 Results Presentation
Telix H1 2026 Appendix 4D and Interim Report
Telix H1 2026 Results Announcement
Telix Half-Year 2026 Operating and Financial Review and Unaudited Interim
Consolidated Financial Statements
101.INS
Inline XBRL Instance Document
101.SCH
Inline XBRL Taxonomy Extension Scheme Linkbase Document
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
 
Telix Pharmaceuticals Limited
Date:
August 20, 2026
By:
/s/ Christian Krautkramer
Name: Christian Krautkramer
Title: Group General Counsel
 
 
 
 

ATTACHMENTS / EXHIBITS

EX-99.1

EX-99.2

EX-99.3

EX-99.4

XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT

XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: R4.htm

IDEA: R5.htm

IDEA: R6.htm

IDEA: R7.htm

IDEA: R8.htm

IDEA: R9.htm

IDEA: R10.htm

IDEA: R11.htm

IDEA: R12.htm

IDEA: R13.htm

IDEA: R14.htm

IDEA: R15.htm

IDEA: R16.htm

IDEA: R17.htm

IDEA: R18.htm

IDEA: R19.htm

IDEA: R20.htm

IDEA: R21.htm

IDEA: R22.htm

IDEA: R23.htm

IDEA: R24.htm

IDEA: R25.htm

IDEA: R26.htm

IDEA: R27.htm

IDEA: R28.htm

IDEA: R29.htm

IDEA: R30.htm

IDEA: R31.htm

IDEA: R32.htm

IDEA: R33.htm

IDEA: R34.htm

IDEA: R35.htm

IDEA: R36.htm

IDEA: R37.htm

IDEA: R38.htm

IDEA: R39.htm

IDEA: R40.htm

IDEA: R41.htm

IDEA: R42.htm

IDEA: R43.htm

IDEA: R44.htm

IDEA: R45.htm

IDEA: R46.htm

IDEA: R47.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: tlx-20260630_htm.xml



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings